ClinicalTrials.Veeva

Menu

Image-Guided Tumorboost of Bladder Cancer

University of Aarhus logo

University of Aarhus

Status and phase

Completed
Phase 2
Phase 1

Conditions

Bladder Neoplasms

Treatments

Radiation: Radiation boost

Study type

Interventional

Funder types

Other

Identifiers

NCT00963404
M-20080210
CIRRO IP 070109 DaBlaCa-1

Details and patient eligibility

About

The purpose of the study is to increase the radiation dose (Boost) to the bladder tumor. The bladder cancer patients included in the study will undergo tumor demarcation. The bladder demarcations will then be the target for an image-guided boost delivered precisely to the expected tumor site.

Enrollment

19 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Muscle invasive bladder cancer (transitional carcinoma)
  • Unifocal
  • TNM stage T2a-4a, N0-1, M0
  • unfit for radical cystectomy

Exclusion criteria

  • Hyperthyroidism
  • Multinodular goiter
  • Pregnancy
  • Breast feeding
  • WHO preformance status more than 2
  • Iodine allergy
  • MRI or CT contrast media allergy
  • Bi-lateral hip-prosthesis

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

19 participants in 1 patient group

Tumor-boost
Experimental group
Description:
Image-guided tumorboost of the bladder cancer.
Treatment:
Radiation: Radiation boost

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems